CLEARMIND MEDICINE ANNOUNCES IRB APPROVAL FOR PHASE 1/2A CLINICAL TRIAL FOR ALCOHOL USE DISORDER AT TEL AVIV SOURASKY MEDICAL CENTER

Reuters · 07/03 12:47

Please log in to view news